Evidence map›Paper›PMID 22347719›Full record

ArticleWiley interdisciplinary reviews. Membrane transport and signaling2012

Calcium channels of schistosomes: unresolved questions and unexpected answers.

Vicenta Salvador-Recatalà, Robert M Greenberg

Open access · greenAbstract read
In one paragraph

Article in Wiley interdisciplinary reviews. Membrane transport and signaling, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Article
  3. Therapeutic challenges of schistosomiasis: mechanisms of action and current limitations.Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2025
    Review
  4. Article
  5. Pathogens (Basel, Switzerland) · 2021
    Article
  6. Article
  7. Schistosoma mansoni sarco/endoplasmic reticulum CaJournal of bioenergetics and biomembranes · 2020
    Review
  8. Identification of annotated bioactive molecules that impair motility of the blood fluke Schistosoma mansoni.International journal for parasitology. Drugs and drug resistance · 2020
    Article
  9. Article
  10. Article
  11. Schistosome infection and its effect on pulmonary circulation.Global cardiology science & practice · 2019
    Review
  12. Article
  13. Article
  14. Article
  15. Ion channels and drug transporters as targets for anthelmintics.Current clinical microbiology reports · 2014
    Article
  16. Review
  17. Review
  18. Natural products as a source for treating neglected parasitic diseases.International journal of molecular sciences · 2013
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Vicenta Salvador-RecatalàDepartment of Pathobiology, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Robert M Greenberg
University of Pennsylvania · US

Funding

POTENTIAL TARGETS FOR NEW ANTISCHISTOSOMAL AGENTSR01AI040522 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI GREENBERG, ROBERT M · 1998 to 2006
$1.5M
Function and pharmacology of schistosome multidrug resistance proteinsR01AI073660 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI GREENBERG, ROBERT M · 2007 to 2010
$1.4M
Transformation of C. elegans with a novel schistosome calcium channel subunitR21AI082390 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI GREENBERG, ROBERT M · 2009 to 2010
$431k
TICK SYSTEMATICS ON A GLOBAL BASISR01AI030026 · NIAID · GEORGIA SOUTHERN UNIVERSITY · PI KEIRANS, JAMES E · 1990 to 1994
–
NIAID NIH HHS N01 AI030026NIAID NIH HHS R01 AI040522NIAID NIH HHS R01 AI073660NIAID NIH HHS R21 AI082390
6 · The paper itself

Abstract

Parasitic flatworms of the genus Schistosoma are the causative agents of schistosomiasis, a highly prevalent, neglected tropical disease that causes significant morbidity in hundreds of millions of people worldwide. The current treatment of choice against schistosomiasis is praziquantel (PZQ), which is known to affect Ca(2+) homeostasis in schistosomes, but which has an undefined molecular target and mode of action. PZQ is the only available antischistosomal drug in most parts of the world, making reports of PZQ resistance particularly troubling. Voltage-gated Ca(2+) (Ca(v)) channels have been proposed as possible targets for PZQ, and, given their central role in the neuromuscular system, may also serve as targets for new anthelmintic therapeutics. Indeed, ion channels constitute the majority of targets for current anthelmintics. Ca(v) channel subunits from schistosomes and other platyhelminths have several unique properties that make them attractive as potential drug targets, and that could also provide insights into structure-function relationships in, and evolution of, Ca(v) channels.

Identifiers

PMID22347719
PMCPMC3278165
OpenAlexW2084057894

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.